OTC · Financial Statements
Epigenomics AG (EPGNF) Financial Statements
$1.12
OTC: EPGNF
Market Cap $1.00M
Overview Financials Dividend Epigenomics AG most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $6.0M $0 $0 $0 $0 Operating Profit $-2.0M $-12.0M $-4.0M $-1.0M $0 Net Profit $-2.0M $-12.0M $-4.0M $-3.0M $0 EPS $-4.33 $-14.78 $-5.23 $-3.82 $-0.36 Op Margin -38.0% -2484.7% -1231.2% — -1400.0%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $25.0M $16.0M $13.0M $1.0M $0 Total Liabilities $3.0M $6.0M $21.0M $12.0M $12.0M Cash $23.0M $10.0M $2.0M $1.0M $0 Borrowings $0 $1.0M $12.0M $11.0M $11.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-4.0M $-12.0M $-6.0M — — Investing Cash Flow $1.0M $-3.0M $0 — — Financing Cash Flow $0 $0 $0 — — Net Cash Flow $19.0M $-13.0M $-6.0M — — Free Cash Flow $-4.0M $-13.0M $-6.0M $0 $0
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.76 FCF Yield -2185.58% Quick Ratio 2.12 Interest Coverage -92.70 Return 1Y 0.00% Return 3Y -72.68% Return 5Y —
Screens featuring this stock